Chelsea Therapeutics Intl Ltd fka CHIP

[surf1944]

Chelsea Therapeutics (CHTP) is trading around $4. CHTP is a biotechnology company, based in North Carolina. These shares have traded in a range between $1.94 to $8.20 in the last 52 weeks. The 50 day moving average is $4.29 and the 200 day moving average is $4.69. CHTP is estimated to lose about 86 cents per share in 2011. Insiders have been buying CHTP shares. One insider bought 40,000 shares in March, which you can see here. Chelsea is pursuing an orphan drug strategy for a drug called Northera (Droxidopa) which is for the treatment of hypotension. This treatment has been approved and marketed in Japan for over 15 years, and generates about $50 million in revenue in that country. You can read more about this and other key products in their pipeline here.

Cash and debt info on CHTP: According to Yahoo Finance, CHTP has about $47.5 million in cash and basically no debt. The cash balance is equal to about 77 cents per share.

http://seekingalpha.com/article/262559-6-cash-rich-biotech-stocks-with-catalysts?source=yahoo